Top Tech Companies (47)
Care Access is a leading decentralized research organization (DRO) that breaks down traditional barriers in clinical research for patients, sponsors, and physicians. Its innovative model brings decentralized trials, Sites On Demand™, Virtual PIs, and Mobile Sites to previously-unreachable patient populations to expand the impact of clinical research. Supported by top pharmaceutical and biotech partners across 20 different therapeutic areas, Care Access is scaling and globalizing its new model for clinical trial delivery, where more physicians and patients can engage in life-saving research to develop new therapies faster. To find out how Care Access is transforming the future of clinical trials, visit www.careaccess.com
We create and apply bold new thinking that makes a difference for patients, for our communities, and for our people. We are driving forward new ideas, innovation, testing and the development of new digital products and services to support patients, researchers, and clinicians.
Roivant aims to improve health by rapidly delivering innovative medicines and technologies to patients. We do this by building Vants – nimble, entrepreneurial biotech and healthcare technology companies with a unique approach to sourcing talent, aligning incentives, and deploying technology. The therapies in development across our family of companies target a wide range of diseases including uterine fibroids, endometriosis, prostate cancer, Parkinson’s disease, diabetes, pulmonary arterial hypertension, and multiple rare and fatal pediatric conditions. We focus on disease areas where the magnitude of R&D investment from industry is disproportionately low relative to societal medical needs. In addition to our biopharmaceutical subsidiaries, we also build technology-focused Vants focused on improving the process of developing and commercializing medicines.
Evvy is a female-founded startup building a new understanding of the female body. Our at-home vaginal microbiome test is the first to leverage metagenomic sequencing to help anyone with a vagina understand what’s up down there, why it matters, and what they can do about it. Why the vaginal microbiome? Turns out, at least 30% of people with vaginas suffer from imbalances in the vaginal microbiome every year (read: bacterial vaginosis, yeast infections, and UTIs). What’s more — the latest research has uncovered groundbreaking links between the vaginal microbiome and infertility, STIs, preterm birth, gynecologic cancers, and more. But even though the vaginal microbiome is an important biomarker, women and people with vaginas have never had access to that information about their own bodies — until now.
At Phosphorus, our mission is to extend and improve lives by making genomics a foundational part of everyone’s health and wellness journey. We have built a verticalized genetic testing platform, from wet lab chemistry to software and bioinformatics, allowing us to provide the most comprehensive, medical-grade genetic tests at price points helping to democratize access to genomic information. We seek to partner with and empower healthcare providers to make preventative genomics the norm in medicine.
Since Bio-Rad was founded 70 years ago, we have continued to provide the healthcare industry with innovative and useful products that help life science researchers accelerate the discovery process and medical diagnostic labs obtain faster, better results. Throughout our existence, we have built long-lasting customer relationships that help advance our research and development efforts in the introduction of new products and solutions. Today, Bio-Rad is a global leader, with a team of over 8,000 employees and a global network of operations that serves our life science research and clinical diagnostics customers, helping people live longer, healthier lives.
We lead the global clinical trial performance improvement market by efficiently managing the patient experience through highly-personalized patient-centric services, unrivaled processes, and our team of professional experts. We streamline communication and coordination among clinical trial patients, sites, and stakeholders. We develop mutually beneficial, long-term relationships with clients and vendors who share our dedication and vision to humanize the patient experience.
Creative Diagnostics is a leading manufacturer and supplier of antibodies, viral antigens, innovative diagnostic components, and critical assay reagents. We provide contract biologic R&D and manufacturing services to the diagnostic manufacturers along with GMP biologics manufacturing for the biopharmaceutical market. Our goal is to be a trusted source for all your assay development and manufacturing needs.
Humanity Health is building the premier career acceleration and talent sourcing platform for underrepresented leaders and innovators in healthcare and life sciences. Our platform provides professionals with an unparalleled level of access and support for their career development while simultaneously providing more inclusive and equitable placement outcomes to our employer partners. Humanity Health is backed by Deerfield Management Company, the nation's largest dedicated healthcare investment firm. Humanity Health offers an exciting start-up environment for highly-motivated, purpose-driven, entrepreneurial professionals interested in building and delivering best-in-class solutions with a lens on equity and inclusion.
BenevolentAI is the global leader in the development and application of artificial intelligence (“AI”) for scientific innovation. We aim to accelerate the journey from inventive ideas to medicines for patients by developing AI to generate new treatments for some of the world’s 8,000 untreated diseases.
PWNHealth is a national clinician network serving all 50 states and Puerto Rico with telehealth and telegenetic services. Our model enables safe and easy access to diagnostic testing. Our solutions provide the clinical, legal, and technological framework to facilitate large-scale consumer testing across key healthcare markets.
With a potential 60 percent increase in the number of cancer cases globally in the next two decades and a decrease in the number of pathologists relative to this diagnostic demand, the need to expedite advancements in pathology is pressing. This issue is further exacerbated by the fact that pathology — despite being the foundation of diagnosis — has yet to become digital. Led by a team of experts in pathology, machine learning, healthcare, and business, Paige strives to make it possible to not only provide additional information from digital slides to help pathologists perform their diagnostic work efficiently and accurately, but also to go beyond this traditional work to extract new diagnostic information from pathology slides and patient samples that have the potential to support informed treatment pathways for patients. Paige technology is also helping life sciences companies evaluate and design personalized treatments for patients.
Scismic is a tech platform built by scientists to help biotechs grow qualified and diverse scientific teams. Our specialized algorithm accurately targets relevant candidates for faster hiring. We are funded by the NIH to reduce bias in candidate evaluation through our gender- and race-blind skills matching technology, so you can hire scientists from all walks of life with the skills you need.
Pulse Analytics builds business intelligence tools that help decision-makers in oncology and other specialty therapeutic areas reduce access barriers and restrictions in the healthcare industry. Pharma market access teams utilize our tools to understand the complex connections, policies, and key influencers at healthcare organizations to deliver targeted insights and support their customer engagement strategies. We go above traditional data platforms by operating in a highly specialized space and partnering with industry experts allowing our tools to provide tailored experiences that meet the unique needs and challenges of our clients.
Melonfrost has created a novel way to modify living things. By combining machine learning and evolutionary biology, our Maia™ software can steer the evolution of organisms in real-time. Our platform, which includes our proprietary Evolution Reactor™, is the dawn of the next generation of biotechnology tools - allowing us to more efficiently solve problems in therapeutics, biomaterials, food, and energy.
Life sciences and biotechnology company with a mission to help people to heal. Working with leading hospitals and universities on developing evidence based clinical nutrition products to enhance patient outcomes. We're very proud to have earned the trust of some of the most demanding and discerning clients in medicine, US special forces and professional sports
Metsera is a clinical-stage biopharmaceutical company accelerating the next generation of medicines for obesity and metabolic diseases. Metsera is advancing a broad portfolio of oral and injectable incretin, non-incretin and combination therapies with potential best-in-class profiles to address multiple therapeutic targets and meet the future needs of a rapidly evolving weight loss treatment landscape. Founded in 2022 by Population Health Partners and ARCH Venture Partners, Metsera has raised $290 million in financing from leading healthcare investors and is based in New York City.
Celmatix is a next-generation women’s health company transforming the way women and their physicians leverage genomics and data to make more informed, proactive reproductive health decisions. Since its foundation in 2009, Celmatix has been committed to empowering women with genetic insights about their fertility and reproductive health.
Our mission is to fight cancer cooperatively instead of individually by connecting scientists and pathologists for online collaboration. HistoWiz provides fast, global access to digital whole-slide images, online collaboration tools, low-cost data management, and experimental pathology expertise. The web-based platform accelerates information exchange among scientists, pathologists, and everyday people who are interested in learning more about a certain type of cancer.
Lokavant is a clinical intelligence platform that improves the time, cost, and quality of trial execution through data-driven analytics applications. Lokavant’s platform aggregates and integrates real-time data from disparate trial data sources, and powers advanced analytics enabled by its compendium of proprietary trial data. The suite of applications built on the platform allows study teams to proactively manage their studies, and surfaces insights, driving efficiencies in all scientific and operational use cases. For more information, please visit www.lokavant.com.